S
TEVA icon

SignatureFD’s Teva Pharmaceuticals TEVA Stock Holding History

SignatureFD’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$536K Buy
15,809
+2,505
+19% +$83.4K 0.01% 630
2026
Q1 		$401K Buy
13,304
+558
+4% +$18K 0.01% 689
2025
Q4 		$398K Buy
12,746
+1,233
+11% +$30.4K 0.01% 677
2025
Q3 		$233K Buy
11,513
+1,699
+17% +$29.8K ﹤0.01% 879
2025
Q2 		$164K Buy
9,814
+3,046
+45% +$49.2K ﹤0.01% 1005
2025
Q1 		$104K Sell
6,768
-2,739
-29% -$48.9K ﹤0.01% 1193
2024
Q4 		$210K Buy
9,507
+1,924
+25% +$35K ﹤0.01% 857
2024
Q3 		$137K Buy
7,583
+1,094
+17% +$19.1K ﹤0.01% 1052
2024
Q2 		$105K Buy
6,489
+112
+2% +$1.73K ﹤0.01% 1137
2024
Q1 		$90K Buy
6,377
+1,783
+39% +$22.5K ﹤0.01% 1248
2023
Q4 		$48K Sell
4,594
-438
-9% -$4.09K ﹤0.01% 1489
2023
Q3 		$51.3K Buy
5,032
+2,394
+91% +$22.3K ﹤0.01% 1381
2023
Q2 		$19.9K Sell
2,638
-478
-15% -$3.88K ﹤0.01% 1894
2023
Q1 		$27.6K Buy
3,116
+154
+5% +$1.52K ﹤0.01% 1696
2022
Q4 		$27K Buy
2,962
+1,367
+86% +$11.9K ﹤0.01% 1657
2022
Q3 		$13K Sell
1,595
-388
-20% -$3.43K ﹤0.01% 1957
2022
Q2 		$15K Buy
1,983
+66
+3% +$575 ﹤0.01% 1929
2022
Q1 		$18K Sell
1,917
-481
-20% -$4.01K ﹤0.01% 1900
2021
Q4 		$19K Buy
2,398
+1,023
+74% +$9.23K ﹤0.01% 1812
2021
Q3 		$13K Buy
1,375
+112
+9% +$1.05K ﹤0.01% 1952
2021
Q2 		$13K Buy
1,263
+206
+19% +$2.18K ﹤0.01% 1903
2021
Q1 		$12K Hold
1,057
– – ﹤0.01% 1787
2020
Q4 		$10K Sell
1,057
-272
-20% -$2.61K ﹤0.01% 1710
2020
Q3 		$12K Buy
1,329
+86
+7% +$910 ﹤0.01% 1584
2020
Q2 		$15K Sell
1,243
-263
-17% -$2.97K ﹤0.01% 1435
2020
Q1 		$14K Buy
1,506
+450
+43% +$4.61K ﹤0.01% 1379
2019
Q4 		$10K Sell
1,056
-15
-1% -$134 ﹤0.01% 1475
2019
Q3 		$7K Buy
1,071
+796
+289% +$6.1K ﹤0.01% 1541
2019
Q2 		$3K Sell
275
-984
-78% -$11.9K ﹤0.01% 1707
2019
Q1 		$20K Sell
1,259
-578
-31% -$10.2K ﹤0.01% 1189
2018
Q4 		$28K Sell
1,837
-867
-32% -$17.8K ﹤0.01% 1032
2018
Q3 		$58K Sell
2,704
-560
-17% -$13K 0.01% 820
2018
Q2 		$79K Buy
3,264
+944
+41% +$19.3K 0.01% 698
2018
Q1 		$40K Buy
+2,320
New +$45.3K ﹤0.01% 817
2016
Q4 		– Sell
-4,604
Closed -$212K – 1111
2016
Q3 		$212K Buy
4,604
+438
+11% +$22.9K 0.03% 212
2016
Q2 		$209K Buy
4,166
+413
+11% +$22K 0.03% 180
2016
Q1 		$201K Buy
3,753
+97
+3% +$5.69K 0.03% 168
2015
Q4 		$240K Buy
3,656
+415
+13% +$25.6K 0.05% 129
2015
Q3 		$183K Buy
3,241
+152
+5% +$9.86K 0.04% 143
2015
Q2 		$183K Buy
3,089
+52
+2% +$3.21K 0.04% 154
2015
Q1 		$189K Buy
3,037
+11
+0.4% +$640 0.05% 138
2014
Q4 		$174K Buy
3,026
+90
+3% +$5.01K 0.04% 143
2014
Q3 		$158K Hold
2,936
– – 0.05% 139
2014
Q2 		$154K Hold
2,936
– – 0.05% 143
2014
Q1 		$155K Sell
2,936
-119
-4% -$5.5K 0.06% 88
2013
Q4 		$122K Buy
3,055
+119
+4% +$4.69K 0.04% 124
2013
Q3 		$111K Buy
2,936
+436
+17% +$17K 0.05% 118
2013
Q2 		$98K Buy
+2,500
New +$97.4K 0.05% 121

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

SignatureFD's TEVA Position: Q2 2026 in Review

SignatureFD increased its Teva Pharmaceuticals (TEVA) stake by 19% in Q2 2026, buying an estimated $83.4K and bringing the position to 15,809 shares worth $536K. The position accounts for 0.01% of the portfolio, ranked #630.

SignatureFD first reported a position in TEVA in Q2 2013 and has held it in 48 quarters since. 673 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • SignatureFD held 15,809 shares of Teva Pharmaceuticals worth $536K as of Q2 2026.
  • SignatureFD bought 2,505 Teva Pharmaceuticals shares in Q2 2026, an estimated $83.4K.
  • Teva Pharmaceuticals made up 0.01% of SignatureFD's portfolio in Q2 2026, its #630 holding.
  • SignatureFD first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 48 quarters since.
  • 673 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.